KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
465 [정현정 교수님] 부작용·내성 극복한 신개념 칸디다증 치료제 개발​ 생명과학과 2025.07.10 16
464 [서성배, 이승희 교수님] 뇌는 포도당을 구별한다..비만·당뇨 치료의 단서 찾아​ 생명과학과 2025.07.10 28
463 [이흥규 교수님] 장내 미생물로 난치성 뇌종양 면역치료 효과 높인다​ 생명과학과 2025.07.02 122
462 [이흥규 교수님] 짠 음식의 뇌종양 악화 유발 원인 세계 최초 밝혀​ 생명과학과 2025.06.04 316
461 [김세윤 교수님] 2025 KAIST 교육혁신의 날 KAIST 교육혁신상 수상 생명과학과 2025.05.21 338
460 [허원도 교수님] 2025 KAIST 리서치데이에서 KAIST 대표연구성과 10선 선정 생명과학과 2025.05.23 395
459 [허원도 교수님] 세계 최초 유전자 가위로 원하는 RNA ‘콕’ 집어 아세틸화 성공 생명과학과 2025.06.10 400
458 [정현정 교수님] 슈퍼박테리아 방패 ‘바이오필름’ 무력화 치료 플랫폼 개발​ 생명과학과 2025.05.30 460
457 [한진희 교수님] 심리적 공포기억 조절 뇌 회로 최초 규명-트라우마 치료 새 전기​ 생명과학과 2025.05.15 483
456 제1회 강창원 교육상 시상식 개최 (2025년 3월 5일) file 생명과학과 2025.03.26 776
455 [허원도, 김재훈, 손종우 교수님] 제54주년 개교기념식 우수교원 포상 생명과학과 2025.02.14 807
454 [김호민 교수님] 선천성면역을 조절하는 인공단백질 디자인, 차세대 백신·면역 치료제 개발 가능성 제시​ 생명과학과 2025.02.14 873
453 [이광록 교수님] 코로나바이러스 전염 메커니즘 규명​ 생명과학과 2025.02.17 885
452 [허원도 교수님] 머릿속 별세포를 비춰라! 새로운 뇌졸중 치료 전략 제시 생명과학과 2025.02.14 885
451 [강석조 교수님] 암세포 사멸과 연관된 대사를 관장하는 최상위인자 규명​ 생명과학과 2025.03.11 955
450 [김세윤, 이광록, 조원기 교수님] 암 발생 현상 등 유전자 발현 조절 원리 규명​ 생명과학과 2025.02.03 997
449 [임대식 교수님] 3·1문화상(자연과학 부문) 수상 생명과학과 2025.01.13 1018
448 [김윤기 교수님] 원형 RNA로 특정 유전자 표적 치료한다​ 생명과학과 2024.12.18 1035
447 [정현정 교수님] 우리 대학 교원 6인, Y-KAST 회원 선출 생명과학과 2024.12.18 1085
446 [정민환 교수님] 뇌 신경활동의 시간적 스케일 규명 생명과학과 2024.12.24 1100
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 24 Next
/ 24